Back

The European Medicines Agency's list of critical medicines: policies and impact on cardiovascular drug availability

14 April 2026 (13:15 - 13:30)
Organised by: Logo
Congress Presentation Part of: Critical medicines, critical times: addressing drug availability for arrhythmia patients topic type Antiarrhythmic Drug Treatment EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Ms Maria Luisa Ronconi

(Belgium)

3 More presentations in this session

Presentation thumbnail
Mapping the crisis: insights from the EHRA survey on anti-arrhythmic drug availability
Doctor P. Postema (Amsterdam, NL)
Video
Presentation thumbnail
Fostering innovation: advancing research and development of next-generation anti-arrhythmic drugs
Associate Professor C. Remme (Amsterdam, NL)
Video
Presentation thumbnail
Ensuring access to critical drugs: harnessing policy, technology, and advocacy
Professor L. Szumowski (Warsaw, PL)
Slides Video

Access the full session

Session thumbnail
Critical medicines, critical times: addressing drug availability for arrhythmia patients topic type
Video

The Event

Event poster

EHRA 2026

14 April 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
The future of ESC
12 April 2026
thumbnail
Congress Session
From innovation to regulation: the evolving landscape of cardiovascular devices in Europe
19 February 2026
thumbnail
Congress Session
Optimising cardiovascular care through multidisciplinary approaches and pharmacological strategies
31 August 2025
thumbnail
Congress Presentation
Repurposing drugs for heart failure - discussion
10 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources